Kerala Targets Life Sciences Boom As Bio Connect 4.0 Draws Rs 713 Crore In Investment Pledges

Kerala has attracted investment interest worth around Rs 713 crore in the life sciences and biomedical sectors through Bio Connect 4.0, a two-day international expo and conclave that concluded here on Friday, bringing together industry leaders, researchers and investors to explore opportunities in the state.

Organised by the Kerala State Industrial Development Corporation (KSIDC), the event saw the exchange of three memoranda of understanding (MoUs) and four expressions of interest (EoIs), according to a government release. The proposed investments are expected to support the development of Kerala’s life sciences ecosystem, with a focus on research, innovation and commercialisation.

The participating organisations included Bharat Biome Life Sciences Pvt Ltd, Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB), HLL Lifecare Limited, In.Vent India Diagnostica Pvt Ltd, Aqua Nova Biosystems Pvt Ltd, Medgrow Bio Life Solutions Pvt Ltd and Foot Pro Solutions Pvt Ltd.

More than 600 delegates and 45 exhibitors participated in the conclave, which explored Kerala’s potential across several emerging areas, including artificial intelligence, advanced therapies, nutraceuticals, next-generation biologics and biomedical innovation.

Addressing the valedictory function, KSIDC Managing Director Snehil Kumar Singh said the state’s ambition extended beyond attracting capital to building an ecosystem that could turn investments into innovations, businesses, employment opportunities and solutions for society.

He stressed the need for Kerala to move beyond manufacturing and strengthen the entire life sciences value chain, from research and development to validation, commercialisation and access to global markets.

The state is seeking to improve its investment appeal through initiatives such as the Bio360 Life Sciences Park, investment facilitation measures and SARAL Kerala. These efforts aim to make it easier for companies to develop, manufacture and scale up life sciences products.

Singh said Kerala wanted to create conditions in which globally recognised life sciences companies could emerge from the state through deliberate ecosystem-building rather than chance.

The conclave has placed renewed focus on Kerala’s ability to translate its scientific and research capabilities into commercially viable businesses. The extent to which the investment proposals materialise into projects, jobs and new technologies will be an important measure of the initiative’s long-term impact.